Award
Delivery Order #SPE2DP26F3213
Short-Term Delivery Order for Mafenide Acetate by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$1,961.10
Ceiling
$1,961.10
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 17, 2026
Identifier
SPE2DP26F3213
NAICS
424210
This contract is a delivery order under a pre-existing indefinite delivery vehicle (IDV) definitive pharmaceutical supply contract. The recipient, DMS Pharmaceutical Group Inc., a pharmaceutical distributor known for supplying critical drug inventories to federal health agencies, is tasked with providing Mafenide Acetate cream. This product is significant for its role in treating burn wounds and preventing infections, thereby supporting vital healthcare operations. The scope involves the timely delivery of this specific topical medication within a brief performance period. This delivery order is part of a larger ongoing pharmaceutical supply framework, ensuring agencies maintain access to essential treatments. The award followed the strategic multi-year contract framework established earlier, indicating continuity rather than a sole-source or new competitive bid. Key dates include the award and performance timeframe early in 2026. This award highlights a focused effort to replenish critical pharmaceutical stock efficiently within the established supply chain.
Description
8511951947!MAFENIDE ACETATE CR